217 related articles for article (PubMed ID: 10741702)
1. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
[TBL] [Abstract][Full Text] [Related]
2. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Lung; 2001; 179(4):197-207. PubMed ID: 11891611
[TBL] [Abstract][Full Text] [Related]
6. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(2):103-11. PubMed ID: 12953149
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
8. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report.
Kao CH; ChangLai SP; Chieng PU; Yen TC
Cancer; 1998 Jul; 83(1):64-8. PubMed ID: 9655294
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.
Safran H; King T; Choy H; Gollerkeri A; Kwakwa H; Lopez F; Cole B; Myers J; Tarpey J; Rosmarin A
Cancer; 1996 Sep; 78(6):1203-10. PubMed ID: 8826941
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
[TBL] [Abstract][Full Text] [Related]
14. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
15. Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancer.
Yang TJ; Aukema TS; van Tinteren H; Burgers S; Valdés Olmos R; Verheij M
Mol Imaging Biol; 2010 Apr; 12(2):174-80. PubMed ID: 19756867
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
[TBL] [Abstract][Full Text] [Related]
17. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression.
Yeh JJ; Hsu WH; Wang JJ; Ho ST; Kao A
Respiration; 2003; 70(1):32-5. PubMed ID: 12584388
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m methoxy-isobutyl-isonitrile chest single photon emission computed tomography to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer: comparison with computed tomography.
Shiau YC; Hsieh JF; Tsai SC; Ho YJ; Sun SS; Kao CH
Anticancer Res; 2000; 20(5C):3751-4. PubMed ID: 11268449
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Changlai SP; Lee JK
J Nucl Med; 2001 Jan; 42(1):17-20. PubMed ID: 11197970
[TBL] [Abstract][Full Text] [Related]
20. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
